Evaluation of these bioinfomatic datasets results revealed that NLGN4X expression was higher in triple negative breast cancer cells, particularly the basal subtype and tissues versus non-triple-negative sets. This evidence concerns the gene NLGN4X and triple-negative breast carcinoma.